Skip to main content

ADVERTISEMENT

population health

Research in Review
06/29/2017
JCP Editors
Despite a small decline in chronic opioid use after 2010, recent research suggests that 40% of older patients with rheumatoid arthritis (RA) still take opioids regularly as of 2014, published in Arthritis &...
Despite a small decline in chronic opioid use after 2010, recent research suggests that 40% of older patients with rheumatoid arthritis (RA) still take opioids regularly as of 2014, published in Arthritis &...
...
06/29/2017
Journal of Clinical Pathways
Research in Review
06/28/2017
JCP Editors
Intensified regimens improve event-free survival (EFS) and overall survival (OS) in patients newly diagnosed with diffuse large B-cell lymphoma (DLBCL) compared with standard therapy, according to research presented...
Intensified regimens improve event-free survival (EFS) and overall survival (OS) in patients newly diagnosed with diffuse large B-cell lymphoma (DLBCL) compared with standard therapy, according to research presented...
...
06/28/2017
Journal of Clinical Pathways
Research in Review
06/27/2017
JCP Editors
A targeting agent is more effective in improving progression-free survival (PFS) and overall survival (OS) than conventional therapy in older patients with a treatment-naïve B-cell malignancy, according to research...
A targeting agent is more effective in improving progression-free survival (PFS) and overall survival (OS) than conventional therapy in older patients with a treatment-naïve B-cell malignancy, according to research...
A...
06/27/2017
Journal of Clinical Pathways
Research in Review
06/27/2017
JCP Editors
Clinical trial participation for patients with cancer often result in measurable benefits, including lowered costs and extended survival. ----- Related Content Trial Shows Precision Medicine Improves Cancer...
Clinical trial participation for patients with cancer often result in measurable benefits, including lowered costs and extended survival. ----- Related Content Trial Shows Precision Medicine Improves Cancer...
...
06/27/2017
Journal of Clinical Pathways
Research in Review
06/26/2017
JCP Editors
Combination therapy involving a novel treatment is associated with reduced risk of death and improved progression-free survival (PFS) in patients with advanced multiple myeloma, according to research presented at the...
Combination therapy involving a novel treatment is associated with reduced risk of death and improved progression-free survival (PFS) in patients with advanced multiple myeloma, according to research presented at the...
...
06/26/2017
Journal of Clinical Pathways
Research in Review
06/26/2017
JCP Editors
Results of a recent study offer insight into the effects of shifting treatment patterns of non-small cell lung cancer (NSCLC) treatment on patient outcomes, and for furthering community oncology benchmark...
Results of a recent study offer insight into the effects of shifting treatment patterns of non-small cell lung cancer (NSCLC) treatment on patient outcomes, and for furthering community oncology benchmark...
...
06/26/2017
Journal of Clinical Pathways
Research in Review
06/23/2017
JCP Editors
Hospital-based end-of-life (EOL) care for older patients with malignant brain tumors is associated with over $16,000 in expenses per patient, according to a research letter published in JAMA Oncology (published...
Hospital-based end-of-life (EOL) care for older patients with malignant brain tumors is associated with over $16,000 in expenses per patient, according to a research letter published in JAMA Oncology (published...
...
06/23/2017
Journal of Clinical Pathways
Research in Review
06/22/2017
JCP Editors
Standard induction chemotherapy is noninferior to high-dose chemotherapy in patients with newly diagnosed acute myeloid leukemia (AML), according to new research published in the Journal of Clinical Oncology...
Standard induction chemotherapy is noninferior to high-dose chemotherapy in patients with newly diagnosed acute myeloid leukemia (AML), according to new research published in the Journal of Clinical Oncology...
...
06/22/2017
Journal of Clinical Pathways
Research in Review
06/22/2017
JCP Editors
Quality improvements are needed to help optimize the implementation of active surveillance among urologists and practice settings, according to a research letter published in JAMA Surgery (published online June 21,...
Quality improvements are needed to help optimize the implementation of active surveillance among urologists and practice settings, according to a research letter published in JAMA Surgery (published online June 21,...
...
06/22/2017
Journal of Clinical Pathways
Research in Review
06/22/2017
JCP Editors
Patients with diffuse large B-cell lymphoma (DLBCL) benefit from improved survival outcomes when treated with a combination therapy rather than monotherapy, according to research presented at the 22nd Congress of the...
Patients with diffuse large B-cell lymphoma (DLBCL) benefit from improved survival outcomes when treated with a combination therapy rather than monotherapy, according to research presented at the 22nd Congress of the...
...
06/22/2017
Journal of Clinical Pathways